StockData
Sigyn Therapeutics, Inc. logo

Sigyn Therapeutics, Inc. (SIGY) stock

SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 0/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $48.16KP/E –Yield –

Sigyn Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Sigyn Therapeutics's profit margin for the twelve months ending Sep 30, 2020 was -37071.5%. For fiscal 2019 it was -2145.3%, against -9243.2% the year before. The highest annual figure on record is -898.0% in fiscal 2014.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2019Dec 31, 2019-2145.3%+7097.9
FY2018Dec 31, 2018-9243.2%+1818.0
FY2017Dec 31, 2017-11061.2%−1836.3
FY2015Dec 31, 2015-9224.9%−8326.8
FY2014Dec 31, 2014-898.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2020Sep 30, 2020-7720.1%−7538.5
Q1 FY2020Mar 31, 2020-33225.1%−33355.0
Q4 FY2019Dec 31, 2019-53816.4%−53422.8
Q3 FY2019Sep 30, 2019-431.7%+4893.7
Q2 FY2019Jun 30, 2019-181.6%+3012.5
Q1 FY2019Mar 31, 2019129.9%+715.0
Q3 FY2018Sep 30, 2018-393.6%−169.9
Q2 FY2018Jun 30, 2018-5325.4%−5097.2
Q1 FY2018Mar 31, 2018-3194.1%–
Q3 FY2017Sep 30, 2017-585.1%–
Q2 FY2017Jun 30, 2017-223.7%–
Q1 FY2017Mar 31, 2017-228.3%–

More Sigyn Therapeutics figures

See a number that looks wrong?